China SXT Pharmaceuticals(SXTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SXTC China SXT Pharmaceuticals

Pre-Mkt 05-14 06:10:07 EDT

1.59

-0.01

-0.62%

盘前1.54

-0.03-1.91%

05:23 EDT

High1.59	Low1.50	Vol19.38K
Open1.50	D1 Closing1.60	Amplitude5.63%
Mkt Cap4.70M	Tradable Cap4.27M	Total Shares2.96M
T/O30.73K	T/O Rate0.72%	Tradable Shares2.68M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SXTC","market":"US","secType":"STK","nameCN":"China SXT Pharmaceuticals","latestPrice":1.59,"timestamp":1778702400000,"preClose":1.6,"halted":0,"volume":19379,"hourTrading":{"tag":"盘前","latestPrice":1.54,"preClose":1.57,"latestTime":"05:23 EDT","volume":85,"amount":134.120004,"timestamp":1778750605164,"change":-0.03,"changeRate":-0.019108,"amplitude":0.038217},"delay":0,"changeRate":-0.0062500000000000056,"floatShares":2684800,"shares":2958100,"eps":-22.460867,"marketStatus":"Pre-Mkt","change":-0.01,"latestTime":"05-14 06:10:07 EDT","open":1.5,"high":1.59,"low":1.5,"amount":30732.545661499997,"amplitude":0.05625,"askPrice":1.57,"askSize":5,"bidPrice":1.39,"bidSize":32,"shortable":3,"etf":0,"ttmEps":-22.460867,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778765400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1546578000000,"exchange":"NASDAQ","adjPreClose":1.57,"preHourTrading":{"tag":"盘前","latestPrice":1.54,"preClose":1.57,"latestTime":"05:23 EDT","volume":85,"amount":134.120004,"timestamp":1778750605164,"change":-0.03,"changeRate":-0.019108,"amplitude":0.038217},"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.59,"latestTime":"19:11 EDT","volume":337,"amount":506.371,"timestamp":1778713896255,"change":-0.09,"changeRate":-0.056604,"amplitude":0.056604},"volumeRatio":1.2077604879188835},"requestUrl":"/m/hq/s/SXTC/wiki","defaultTab":"wiki","newsList":[{"id":"2633896187","title":"China SXT Pharmaceuticals raises $3.5 million in private placement of shares, warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2633896187","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633896187?lang=en_us&edition=fundamental","pubTime":"2026-05-05 05:01","pubTimestamp":1777928496,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals entered private placement with non-U.S. investors on May 1, 2026, raising gross proceeds of $3.5 million.Deal issued 3,500,000 Class A ordinary shares, no par value, alongside 3,500,000 warrants exercisable at $1 per share.Warrants became exercisable on issuance, expire five years from issuance, include customary anti-dilution adjustments, allow cash or cashless exercise.Offering closed May 2, 2026; net proceeds earmarked for working capital, general corporate purposes.Securities sold in unregistered transaction under Regulation S.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gatherin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL6ZK7j6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630444312","title":"China SXT Pharmaceuticals Co-CEO Simon Lim files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2630444312","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630444312?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:01","pubTimestamp":1777320102,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals filed an initial Form 3 naming Simon Lim Sze Beng as co-chief executive officer.Filing reported holdings as of Jan. 20, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL982gHN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626818724","title":"China SXT Pharmaceuticals prices 2 million-share registered offering for USD 760,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2626818724","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626818724?lang=en_us&edition=fundamental","pubTime":"2026-04-09 21:06","pubTimestamp":1775739971,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals entered securities purchase agreement on April 7, 2026 to sell 2,000,000 Class A ordinary shares.Closing expected April 9, 2026, subject to customary conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL5pMMCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621706107","title":"China SXT Pharmaceuticals, Inc. Announces Share Re-classification","url":"https://stock-news.laohu8.com/highlight/detail?id=2621706107","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621706107?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:00","pubTimestamp":1774270800,"startTime":"0","endTime":"0","summary":"TAIZHOU, China, March  23, 2026 (GLOBE NEWSWIRE) --  China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development, m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260426/0/en/China-SXT-Pharmaceuticals-Inc-Announces-Share-Re-classification.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTC","SXT","IE0009354923.USD","BK4007","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608887798","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:33 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2608887798","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608887798?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:33","pubTimestamp":1770129208,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:33 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nAQN2LKH0Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608814944","title":"China SXT Pharmaceuticals Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2608814944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608814944?lang=en_us&edition=fundamental","pubTime":"2026-02-03 08:50","pubTimestamp":1770079818,"startTime":"0","endTime":"0","summary":"19:50 EST China SXT Pharmaceuticals (SXTC) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/china-sxt-pharmaceuticals-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/china-sxt-pharmaceuticals-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","IE0009354923.USD","BK4109","SXT","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608886768","title":"Here’s Why China SXT Pharmaceuticals Stock (SXTC) Rocketed Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2608886768","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608886768?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:18","pubTimestamp":1770041886,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals stock was up ahead of the company’s reverse stock split tomorrow.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/heres-why-china-sxt-pharmaceuticals-stock-sxtc-rocketed-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/heres-why-china-sxt-pharmaceuticals-stock-sxtc-rocketed-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTC","BK4109","SXT","BK4007","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607046273","title":"China SXT Pharmaceuticals Announces 1-for-150 Share Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=2607046273","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607046273?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:00","pubTimestamp":1769781612,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals Inc.  announced a 1-for-150 share consolidation of its Class A ordinary shares, effective February 3, 2026. After the consolidation, approximately 957,960 Class A ordinary shares will be outstanding, and the shares will continue to trade under the symbol \"SXTC\" on Nasdaq with a new CUSIP number. All outstanding stock options and warrants will be adjusted proportionately.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on January 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL3cbq9j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4588","SG9999014039.USD","SXTC","BK4585","SG9999014021.USD","LU2095319765.USD","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","BK4112","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014013.SGD","BK4007","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603832679","title":"China SXT Pharmaceuticals Unveils Plans to Integrate AI for Enhanced Transparency, Quality Control, and Supply Chain Management in TCM Raw Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2603832679","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603832679?lang=en_us&edition=fundamental","pubTime":"2026-01-15 22:00","pubTimestamp":1768485622,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals Unveils Plans to Integrate AI for Enhanced Transparency, Quality Control, and Supply Chain Management in TCM Raw Materials. China SXT Pharmaceuticals Inc. has announced a strategic initiative to apply artificial intelligence  technology across its Traditional Chinese Medicine  raw-material supply chain. The company plans to explore the use of AI-supported analytical methods in areas such as cultivation environment monitoring, origin and authenticity assessment, quality evaluation, and material grading. Additionally, China SXT intends to examine the application of AI in supply-demand forecasting and circulation efficiency, aiming to achieve more consistent and data-informed supply chain management. The initiative is designed to enhance supply chain transparency, operational stability, quality oversight, traceability, and resource planning, while supporting the company's broader strategy of integrating technology into operational management.Disclaimer: This news","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL4rYM3c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU0314104364.USD","LU2210149790.SGD","BK1515","LU2210150020.SGD","IE00B64PRP62.GBP","BK1191","LU2095319765.USD","NDAQ","SG9999014005.SGD","SG9999014039.USD","BK4585","BK4112","SG9999014013.SGD","SG9999014021.USD","BK4588","BK1606","SXTC","IE00BKPKM429.USD","00570","IE00B3QW5Z07.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2603514985","title":"CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN","url":"https://stock-news.laohu8.com/highlight/detail?id=2603514985","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603514985?lang=en_us&edition=fundamental","pubTime":"2026-01-15 22:00","pubTimestamp":1768485600,"startTime":"0","endTime":"0","summary":"TAIZHOU, China, Jan.  15, 2026  (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, developm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/15/3219618/0/en/CHINA-SXT-PHARMACEUTICALS-INC-ANNOUNCES-STRATEGIC-INITIATIVE-TO-APPLY-AI-TECHNOLOGY-ACROSS-THE-TCM-SUPPLY-CHAIN.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4551","BK4585","AI","INC","IE0009354923.USD","BK4109","SXT","BK4543","BK4023","SXTC","BK4587","BK4007","BK4528"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2603658055","title":"China SXT Pharmaceuticals Raises $9.1 Million in Registered Direct Offering with Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2603658055","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603658055?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:36","pubTimestamp":1768340173,"startTime":"0","endTime":"0","summary":"The latest update is out from China SXT Pharmaceuticals ( ($SXTC) ). On January 9, 2026, China SXT Pharmaceuticals, Inc. entered into a securities ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-raises-9-1-million-in-registered-direct-offering-with-pre-funded-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-raises-9-1-million-in-registered-direct-offering-with-pre-funded-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTC","SXT","BK4007","BK4109","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602999306","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:50 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2602999306","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602999306?lang=en_us&edition=fundamental","pubTime":"2026-01-10 03:50","pubTimestamp":1767988238,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:50 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nAQN2LH4J6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602306996","title":"China SXT Pharmaceuticals Announces $10 Million Registered Direct Offering of Shares and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2602306996","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602306996?lang=en_us&edition=fundamental","pubTime":"2026-01-10 03:50","pubTimestamp":1767988209,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals Inc. announced it has entered into a definitive agreement with a single investor for the purchase and sale of approximately 66.67 million Class A ordinary shares, or pre-funded warrants in lieu thereof, at a purchase price of $0.15 per share in a registered direct offering. The offering is expected to raise gross proceeds of about $10 million, with the transaction anticipated to close on or about January 12, 2026, subject to customary closing conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on January 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL4xnMkr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4112","LU2095319765.USD","SG9999014021.USD","LU2210150020.SGD","LU2210149790.SGD","BK4585","NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","SG9999014013.SGD","SG9999014039.USD","BK4007","IE00BGHQF748.EUR","SXTC","IE00B3QW5Z07.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602974573","title":"Why Is Penny Stock China SXT (SXTC) Up Almost 200% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602974573","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602974573?lang=en_us&edition=fundamental","pubTime":"2026-01-09 03:23","pubTimestamp":1767900223,"startTime":"0","endTime":"0","summary":"Shares in China SXT Pharmaceuticals ($SXTC) staged a massive rally on Thursday afternoon after the Chinese traditional medicine company launched an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-penny-stock-china-sxt-sxtc-up-almost-200-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-penny-stock-china-sxt-sxtc-up-almost-200-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","IE0009354923.USD","BK4007","SXTC","SXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602011392","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2602011392","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602011392?lang=en_us&edition=fundamental","pubTime":"2026-01-09 02:56","pubTimestamp":1767898609,"startTime":"0","endTime":"0","summary":"FlyExclusive  said early Thursday it has signed an authorized dealership agreement with Starlink, becoming a certified dealer and installer for Starlink's \"high-speed, low-latency aviation connectivity system.\"Shares of FlyExclusive doubled as intraday trading volume catapulted to over 91.5 million from a daily average of about 20,000.China SXT Pharmaceuticals  unveiled an artificial intelligence initiative on Thursday, saying it aims to integrate AI-driven analytics into its product portfolio planning and market intelligence processes.Shares almost tripled as intraday trading volume advanced to over 66.1 million from a daily average of roughly 147,000.Century Therapeutics  reported a private placement in a financing round led by new investor TCGX, for initial gross proceeds of about $135 million.Shares surged 37% as intraday trading volume soared to more than 18.2 million from a daily average of about 1.36 million.Price: 6.81, Change: +3.67, Percent Change: +116.88","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4139","SXTC","BK4539","BK4008","BK4007","FLYX","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601652395","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:34 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2601652395","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601652395?lang=en_us&edition=fundamental","pubTime":"2026-01-08 23:34","pubTimestamp":1767886475,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:34 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nAQN2LGX1Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601458398","title":"China SXT announces launch of Strategic AI Insights Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=2601458398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601458398?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:31","pubTimestamp":1767882663,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals (SXTC) announced the launch of a Strategic Artificial Intelligence (AI) Insights Initiative. This initiative aims to inte...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/china-sxt-announces-launch-of-strategic-ai-insights-initiative-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/china-sxt-announces-launch-of-strategic-ai-insights-initiative-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009354923.USD","BK4551","BK4109","BK4588","BK4528","BK4023","AI","SXT","BK4585","BK4587","BK4007","BK4543","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601602803","title":"China SXT Pharmaceuticals Announces Plans to Integrate AI Analytics for Product Portfolio Optimization, Market Analysis, and AI-Supported Clinic Deployment in Traditional Chinese Medicine Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2601602803","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601602803?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:20","pubTimestamp":1767882012,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals Announces Plans to Integrate AI Analytics for Product Portfolio Optimization, Market Analysis, and AI-Supported Clinic Deployment in Traditional Chinese Medicine Sector. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL6KVBM4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","BK4585","BK1191","LU2095319765.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4007","BK4588","SG9999014039.USD","SG9999014013.SGD","BK1515","00570","BK4112","LU2210150020.SGD","BK1606","SXTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601636075","title":"CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT","url":"https://stock-news.laohu8.com/highlight/detail?id=2601636075","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601636075?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:20","pubTimestamp":1767882000,"startTime":"0","endTime":"0","summary":"TAIZHOU, China, Jan.  08, 2026  (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (\"China SXT\" or the \"Company\"), a specialty pharmaceutical company focusing on the research, developm","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/08/3215463/0/en/CHINA-SXT-PHARMACEUTICALS-INC-ANNOUNCES-STRATEGIC-AI-INSIGHTS-INITIATIVE-TO-OPTIMIZE-TRADITIONAL-CHINESE-MEDICINE-PORTFOLIO-ENHANCE-MARKET-ANALYSIS-AND-EXPLORE-AI-SUPPORTED-CLINIC-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","IE0009354923.USD","BK4588","BK4585","INC","SXT","BK4587","SXTC","BK4007","BK4528","BK4109","BK4023","AI","BK4551"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sxtchina.com","stockEarnings":[{"period":"1week","weight":-0.0966},{"period":"1month","weight":-0.3147},{"period":"3month","weight":-0.3954},{"period":"6month","weight":-0.992},{"period":"1year","weight":-0.9948},{"period":"ytd","weight":-0.9934}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0819},{"period":"3month","weight":0.0896},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.2649},{"period":"ytd","weight":0.0886}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.129972},{"month":2,"riseRate":0.5,"avgChangeRate":-0.09909},{"month":3,"riseRate":0.25,"avgChangeRate":-0.158112},{"month":4,"riseRate":0.125,"avgChangeRate":-0.155346},{"month":5,"riseRate":0,"avgChangeRate":-0.221565},{"month":6,"riseRate":0.714286,"avgChangeRate":0.091345},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.154141},{"month":8,"riseRate":0,"avgChangeRate":-0.184075},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.131032},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.1238},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.076982},{"month":12,"riseRate":0.571429,"avgChangeRate":0.138689}],"exchange":"NASDAQ","name":"China SXT Pharmaceuticals","nameEN":"China SXT Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"China SXT Pharmaceuticals(SXTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest China SXT Pharmaceuticals(SXTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"China SXT Pharmaceuticals,SXTC,China SXT Pharmaceuticals股票,China SXT Pharmaceuticals股票老虎,China SXT Pharmaceuticals股票老虎国际,China SXT Pharmaceuticals行情,China SXT Pharmaceuticals股票行情,China SXT Pharmaceuticals股价,China SXT Pharmaceuticals股市,China SXT Pharmaceuticals股票价格,China SXT Pharmaceuticals股票交易,China SXT Pharmaceuticals股票购买,China SXT Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"China SXT Pharmaceuticals(SXTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest China SXT Pharmaceuticals(SXTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction